+919405117673

Leading Exporter of Anti-D 300 mcg Injection from India – Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd specializes in pharmaceutical exports from India with reliable supply solutions for Anti-D 300 mcg Injection (Anti Rh D Immunoglobulin). We provide fast shipping, export support, and dependable delivery across major South African cities including Johannesburg, Cape Town, Durban, Pretoria, Port Elizabeth (Gqeberha), East London, Bloemfontein, Pietermaritzburg, Polokwane, and Nelspruit (Mbombela).

About Anti-D 300 mcg Injection

Anti-D 300 mcg Injection is an immunoglobulin preparation containing Anti Rh D antibodies. It is generally administered under healthcare supervision in cases where prevention of Rh sensitization is medically required.

Treatment Applications and Medical Use

Healthcare professionals may prescribe Anti-D 300 mcg Injection for:

• Prevention of Rh incompatibility complications in Rh-negative mothers
• Post-delivery administration where clinically recommended
• Management after miscarriage or pregnancy-related procedures requiring prophylaxis
• Prevention of antibody formation after certain blood exposure events
• Supportive preventive treatment as advised by medical specialists

Why Import from Cordium Pharmaceuticals Pvt Ltd?

  • Global pharmaceutical export expertise
  • Fast shipping from India to South Africa
  • Quality-focused medicine sourcing
  • Professional export documentation assistance
  • Bulk supply capabilities for distributors and importers
  • Safe packaging and efficient logistics network

Fast Delivery Locations Across South Africa

We support pharmaceutical shipments to:

Johannesburg | Cape Town | Durban | Pretoria | Port Elizabeth (Gqeberha) | East London | Bloemfontein | Pietermaritzburg | Polokwane | Nelspruit (Mbombela)


Contact for Orders & Export Enquiries

WhatsApp: +91-9405117673
Email: info@cordiumpharma.com

Cordium Pharmaceuticals Pvt Ltd – Delivering Trusted Pharmaceutical Export Solutions with Speed, Quality, and Global Reach

Jun 7th, 2026 10:58 PM